Search Results
Antisense Strategies Against Non-Liver Targets
How to design antisense oligonucleotides for high on-target potency and minimal off-target effect
ASOs - AntiSense Oligonucleotides: what they are and how they work
Antisense Oligonucleotides- Mechanisms of Action and Rational Design
David Corey: Guidelines for Experiments using Antisense Oligonucleotides and Double-Stranded RNAs
Antisense Oligonucleotide - Therapy Update - Stefan-M. Pulst, MD
RNaseH sequences preferences affecting antisense RNA drugs and HIV replication - Jeppe Vinther
Discovering novel genetic targets for fatty liver disease
EASL Studio S4E11 - YI Choice: Gene therapy for liver disease —RNA interference and beyond
Submerge in the Oligonucleotide Emerge: Best Practices for Developing These Complex Biologics
NanoSIMS - Improving the targeting of ASO therapeutic sub-cellular imaging - Webinar
Oligo Meeting 2017 - RNAi Drug Discovery
